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Initially considered as a normal body response to injury, 
inflammation is currently known as a major event contributing to the 
development of many human disorders. Many drugs and bioactive 
molecules have been discovered from medicinal plants and the number is 
still growing by time. Among those medicinal plants used in folk medicines, 
Plantago lanceolata is used to cure inflammatory-related diseases. In our 
previous study, we showed that the n-hexane insoluble fraction of P. 
lanceolata leaves (HIF) demonstrated a potent anti-inflammatory activity 
by inhibiting leukocytes migration in mice. This study aimed to identify the 
active compound from HIF which responsible for the inhibition of 
leukocytes migration in mice, and to investigate the effect of the active 
compound on the level of chemokine (IL-8 and MCP-1) responsible for 
leukocytes migration. P. lanceolata leaves were initially macerated with 
dichloromethane. The dried extract was partitioned using n-hexane to 
obtain n-hexane soluble fraction (HSF) and n-hexane insoluble fraction 
(HIF). Both fractions were evaluated for their anti-inflammatory activity in 
thioglycollate-induced leukocyte migration. The active fraction (HIF)                    
was subjected to a preparative thin-layer chromatography to isolate the 
major compound. The structure of the isolated compound was identified 
based on NMR, IR, and Mass spectra. The compound was identified as 
ursolic acid, based on its spectral data. Ursolic acid at dose of 30, 60, and 
120mg/kg BW inhibited leukocyte migration and reduced the level of IL-8 
and MCP-1). 
Keywords: Plantago lanceolata, anti-inflammatory agents, MCP-1, 
chemokine CCL2, interleukin-8  
 
 
INTRODUCTION  
Leukocyte recruitment from the blood 
circulation to the site of inflammation plays an 
important role in inflammation. This process 
occurs during the development of inflammation 
and is mediated by pro-inflammatory mediators 
called chemoattractant cytokines (chemokines). 
These chemokines are produced to induce 
leukocyte migration. Inhibiting any of the events 
can severely interfere with leukocyte migration to 
the site of inflammation (Chavakis et al., 2005; 
Muller, 2013). The leukocyte migration across 
endothelial cells to inflammatory sites is guided by 
a chemokine gradient. Important chemokines that 
play a crucial role in leukocyte migration are IL-8 
(Gonzalez-Aparicio and Alfaro, 2019) and MCP-1 
(Balamayooran et al., 2011). The roles of 
chemokines in leukocyte migration in 
inflammation have been established in many 
studies (Charo and Taubman, 2004; Turner et al., 
2014). Thus, inhibiting leukocyte migration by 
reducing chemokine levels is a promising 
therapeutic target in inflammatory-related diseases 
(Del Prete et al., 2015; Hopkin et al., 2019).  
 
Medicinal plants provide a broad spectrum 
of chemical structure diversity regarding bioactive 
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natural products. Natural compounds derived 
from herbal medicines are being increasingly 
explored to develop therapeutic agents for various 
diseases, including inflammatory disorders. 
Plantago lanceolata has been used traditionally as 
an herbal remedy for inflammatory disorders that 
occur in the mouth, skin, respiratory tract, 
pharyngeal mucosa, and throat (Dawid-Pać, 2013; 
Vogl et al., 2013). However, only a few scientific 
data are available concerning the anti-
inflammatory compounds from P. lanceolata. 
Previous studies showed that dichloromethane 
extract of the P. lanceolata leaf showed potent 
anti-inflammatory activity by inhibiting NF-κB 
activation (Vogl et al., 2013). 
Further separation of the extract with n-
hexane yielded n-hexane insoluble (HIF) and n-
hexane soluble (HSF) that represent relatively 
non-polar and polar fractions, respectively. An 
anti-inflammatory study of HIF in a murine model 
showed that HIF exerted anti-inflammatory 
activity by inhibiting cyclooxygenase-2 (COX-2) 
activity and reducing chemokine levels (Fakhrudin 
et al., 2017). However, the anti-inflammatory 
compound responsible for the activity has not 
been identified. Therefore, this study aimed to 
isolate and identify the anti-inflammatory 
compound from the HIF and to determine the anti-
inflammatory activity of the HIF in thioglycollate-
induced leukocyte migration. The effect of the 
active compound at the chemokine levels (MCP-1 
and IL-8) was also evaluated.  
 
MATERIAL AND METHODS 
Animals 
Male mice (Balb/C strain, 6 months old, 20-
30g weight,) were from the Laboratory of 
Pharmacology and Toxicology, Department of 
Pharmacology and Clinical Pharmacy, Faculty of 
Pharmacy, UGM. The animals were given free 
access to both a standard commercial pellet diet 
and water. They were kept in the animal house 
with a 12h light/dark cycle at an ambient 
temperature of 25°C. The protocols were in 
accordance with the guideline of the Ethic 
Committee at the Integrated Research and Testing 
Laboratory, UGM (Ethical clearance number 
102/KEC-LPPT/V/2013).  
 
Plant material 
The leaves of P. lanceolata were collected 
from Tawangmangu district, Karanganyar, Jawa 
Tengah, Indonesia. The identity of plant                   
species was authenticated (certificate number 
BF/78/Ident/Det/III/2013) by Dr. Djoko Santosa, 
the botanist in the Faculty of Pharmacy, 
Universitas Gadjah Mada. Fresh leaves of P. 
lanceolata were washed with water, cut into 
smaller-sized pieces, and allowed to overnight at 
room temperature. The leaves were further dried 
in the oven (50ᵒC for 48h). Finally, the dried leaves 
were pulverized for further processing. 
 
Extraction, fractionation, isolation and 
identification 
The powdered leaves (1.7kg) were 
macerated in 5L of dichloromethane for 24h. The 
filtrate was separated in a vacuum-assisted 
Buchner funnel. The maceration process was done 
three times (each with 5L dichloromethane), and 
the filtrates were combined and evaporated in a 
rotary evaporator (Heidolph; Schwabach, 
Germany) to obtain a dry extract (46g). The 
extract (2g) was dissolved in 20mL n-hexane 
assisted by intensive stirring to give n-hexane 
soluble (HSF) and n-hexane insoluble (HIF) 
fractions. This process was repeated three times 
until colorless HSF was obtained. The HIF was 
collected and dried (0.8g). 
After anti-inflammatory evaluation, the 
active fraction (HIF) was subjected to vacuum 
column chromatography on silica gel (Emerck; 
Darmstadt, Germany). The column was eluted first 
with n-hexane followed by n-hexane:ethyl acetate 
(6:1 v/v); next by the portion of 4:1; and 2:1 v/v; 
and then by ethyl acetate and finally, by methanol. 
The fractions were collected according to the 
order of separation to give six combined fractions 
(F1–F6): F1 (460mg); F2 (145mg); F3 (364mg); F4 
(245mg); F5 (555mg); and F6 (429mg). The 
chemical profile of each fraction was monitored by 
a TLC on a silica gel 60 F254 (Emerck; Darmstadt, 
Germany) with n-hexane:ethyl acetate (4:1) as the 
mobile phase and Cerium(IV) sulfate (Sigma-
Aldrich; Missouri, USA) as a reagent to visualize 
the spots. F3–6 showed similar TLC profiles and 
contained the same major compound characterized 
by a dominant spot on the TLC profile. This major 
compound was isolated using preparative TLC.  
In the preparative TLC, the fractions were 
applied as a band into glass-supported preparative 
TLC plates. The band on the plates was eluted with 
n-hexane:ethyl acetate (4:1) as the mobile phase 
in the preparative TLC chamber saturated 
previously with the mobile phase. The silica-
containing band of the major compound was 
scraped gently and collected. The compound was 
extracted from the silica using methanol assisted 
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by intensive magnetic stirring. The silica was 
separated by filtering to give the isolated compound 
(174mg). The structure of the isolated major 
compound was elucidated by interpreting the UV, 
NMR, IR, and mass spectra. UV spectra was 
recorded on UV spectrophotometer (Hitachi U-2800; 
Tokyo, Japan). DELTA2 500MHz spectrometer 
(Jeol; Massachusetts, USA) was used to gain NMR 
spectra. The compound was dissolved in CDCl3, 
and the instrument was operated at 500MHz and 
125.76MHz for 1H- and 13C-NMR, respectively, 
with tetramethylsilane as an internal standard. 
The IR spectra was recorded on a Perkin Elmer 
Spectrum 100 FTIR Spectrometer (Massachusetts, 
USA) in the range of 4000-400cm-1. The LC-MS data 
were generated using Mariner Biospectrometry 
(Cambridge Scientific; Massachusetts, USA) inte-
grated with the high performance liquid chromato-
graphy (HPLC) instrument (Hitachi L 6200; Tokyo, 
Japan) equipped with a Q-TOF mass spectrometer 
fitted with an ESI source (m/z 39 to 1200).   
 
Leukocyte migration assay 
The leukocyte migration assay was done 
according to the protocol from previous studies 
(Fakhrudin et al., 2014). Briefly, the mice were 
divided into control and treatment groups (5 mice 
per group). The treatment groups were given 
intraperitoneal (i.p., 0.2mL) injections of the 
fractions, isolated compound, or indomethacin 
(Sigma-Aldrich; Missouri, USA); whereas the control 
group received solvent (DMSO–saline). After 30min, 
0.5mL of sterile thioglycollate (4%) was injected 
(i.p.) to induce leukocyte migration. The animals 
were sacrificed after 4h and the peritoneal lavage 
was collected and centrifuged (10min, 1200rpm at 
4ᵒC) to obtain cell pellets. The cells were 
resuspended in 1mL PBS and stained with 
methylene blue. The number of cells was counted 
by direct microscopic counts using a Neubauer 
chamber (Assistent; Sandheim, Germany).  
 
Determination of chemokine levels 
The levels of MCP-1 and IL-8) in the 
peritoneal lavage were detected using an ELISA kit 
(Cusabio CSB-E07274m and CSB-E07430m, 
respectively), and were measured in an ELISA 
plate reader (Pioway RT-2100C; Nanjing). The 
assay protocol was done according to the 
instructions recommended by the manufacturer. 
The activity of the fractions or compound to 
reduce chemokine levels was expressed as a 
percent of reduction compared with the solvent-
treated group.  
RESULT AND DISCUSSION 
Inflammation plays a crucial role in the 
development of inflammatory disorders such as  
obesity, arthritis, atherosclerosis, asthma, 
diabetes, sarcopenia, hepatitis and Alzheimer’s 
disease (Chung et al., 2011). The discovery of 
inflammatory agents from natural products, 
especially medicinal plants remains challenging          
as many of the modern drugs developed today         
are derived from plants (Calixto, 2019). Our 
previous study showed that the dichloromethane 
extract of the P. lanceolata leaf showed                    
anti-inflammatory activity by inhibiting NF-κB 
(Vogl et al., 2013). NF-ĸB represents a promising 
target in inflammation and this protein regulate 
the production of pro-inflammatory cytokines           
and mediate inflammatory development.  In the 
previous  study, we found that the n-hexane 
insoluble fraction (HIF) of P. lanceolata 
dichloromethane extract is the active fraction with 
anti-inflammatory activity in mice (Fakhrudin et 
al., 2017). In this study, we isolated the major 
compound from the HIF and evaluated its                 
anti-inflammatory activity by employing 
thioglycollate-induced mice peritonitis as 
pharmacological evidence. This method 
represents a simple bioassay to confirm the anti-
inflammatory of a compound based on the 
inhibition of leukocyte migration (Cash et al., 
2009; Hermida et al., 2017).  
The HIF and HSF were evaluated for                 
their anti-inflammatory activities and the           
chemical profiles of both fractions were presented 
in our previous study (Fakhrudin et al., 2017). The 
HIF demonstrates a higher activity compared            
with the HSF at 400mg/kg BW (Figure 1 and Table 
I). This finding indicates that the most active anti-
inflammatory compound might be present in the 
HIF. Thus, we focused on the HIF and further 
separated it by using vacuum column 
chromatography that resulted in six fractions.           
The TLC profile of the fractions indicated                 
the presence of a major compound (Figure 2).        
We further isolated this major compound using              
a preparative TLC. The structure of the         
isolated major compound was determined               
based on spectral data (13C- and 1H- NMR, MS, IR, 
UV). We identified that compound as                  
ursolic acid (174 mg) (Figure 2). The spectra                  
of the isolated compound were compared                  
with those of ursolic acid in the literature.                    
The isolated ursolic acid appeared as a                         
white powder with a m.p. of 197°C (as a          
reference  (Hossain  and Ismail, 2013) m.p      195°C); 
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Table I. The anti-inflammatory activity of n-hexane insoluble fraction (HIF) and n-hexane soluble fraction 
(HSF) (400mg/kg BW) in thioglycollate-induced leukocyte migration in mice. The mice (5/group) were 
pretreated (i.p.) with the fractions (HIF or HSF), indomethacin (36mg/kg BW), or solvent (DMSO–saline) 
for 30min before stimulation of leukocyte migration using thioglycollate (i.p.). After 4h, the mice were 
sacrificed, and the total leukocytes were counted. HIF: n-hexane insoluble fraction; HSF: n-hexane soluble 
fraction of the P. lanceolata leaf. 
 
Percentage of leukocyte migration* 
mice control solvent indomethacin HSF HIF 
1 7.63 100.00 11.13 88.55 32.74 
2 6.80 100.00 11.19 86.86 31.33 
3 7.03 100.00 12.13 88.65 34.21 
4 7.89 100.00 10.32 90.19 34.09 
5 7.21 100.00 10.89 89.11 32.47 
mean 7.31±0.44 100.00 11.13±0.66 88.67±1.20 32.97±1.20 
 
*the number of migrated leukocytes in the solvent-treated group was set as 100% of leukocyte migration upon 
thioglycollate induction. 
 
 
 
Figure 1. Hexana insoluble fraction inhibited leukocyte migration in thioglycollate-induced mice. The 
mice were pretreated with fractions (HSF or HIF at dose of 400 mg/kg BW), solvent (DMSO–saline), or 
indomethacin (36 mg/kg BW) 30min before the induction of leukocyte migration using thioglycollate 
(i.p.). The data were means ± standard errors (*** p < 0.01; ANOVA/Dunnett) and were relative to the 
solvent-treated group (n = 5). HSF: n-hexane soluble fraction; HIF: n-hexane insoluble fraction of the P. 
lanceolata leaf. 
 
 
 
Figure 2. The structure of ursolic acid and TLC profile of ursolic acid in the HIF. HIF (1), and ursolic acid 
(2) were applied on the silica gel F254 TLC plate and developed using n-hexane:ethyl acetate (4:1). The 
TLC plates were visualized at UV366 nm (A); and sprayed with Cerium sulfate reagent, documented under 
visible light (B); and UV366 nm (C). 
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ESI-MS m/z 457 [M+H]+ (calc. for C30H48O3); UV: 
210 nm; IR (KBr) νmax in cm-1: 3406 (OH), 1092 
(C-O), 2924 (CH), 1690 (C=O) 1458 (C=C); 1H-NMR 
(500 MHz, CDCl3): δ 3.21 (1H, dd, J = 2.2, 9.1 Hz, 
H-3); 5.25 (1H, t, J = 1,5; H-12), 2.17 (1H, d, J = 11.0 
Hz, H-18), 1.28 (3H, s, H-23), 0.91 (3H, s, H-24), 
1.13 (3H, s, H-25), 0.98 (3H, s, H-26), 1.25 (3H, s, 
H-27), 0.94 (3H, d, J = 6.5 Hz, H-29), 1.08 (3H, d, J = 
6.0 Hz, H-30). 13C-NMR (500 MHz, CDCl3): δC 39.2 
(C-1), 27.4 (C-2), 79.2(C-3), 38.9 (C-4), 77.4 (C-5), 
17.2 (C-6), 33.1 (C-7), 48.1 (C-8), 76.9 (C-9), 37.2 
(C-10), 17.1 (C-11), 126.0 (C-12), 138.1(C-13), 
52.8 (C-14), 29.4  (C-15), 23.8  (C-16),  55.3    (C-17),  
77.2 (C-18), 39.6 (C-19), 47.6 (C-20), 29.9 (C-21), 
38.9 (C-22), 28.3 (C-23), 15.6 (C-24), 14.3 (C-25), 
15.7 (C-26), 23.5 (C-27), 180.4 (C-28), 21.4 (C-29), 
18.5 (C-30). The 13C-NMR, 1H-NMR, and mass 
spectra data of the isolated ursolic acid (Figure 3). 
The ursolic acid isolated in this study has a  similar 
spectrum to that identified in previous publications 
(Geană et al., 2014; Hossain and Ismail, 2013). The 
presence of ursolic acid in the P. lanceolata leaf 
was also reported previously (Baumgartner et al., 
2011). Interestingly, ursolic acid was also found in 
P. major, a plant from the same Genus that has a 
wider distribution (Ringbom et al., 1998).  
 
 
 
 
 
Figure 3. The spectra of ursolic acid isolated from the leaves of P. lanceolata obtained from NMR 
spectroscopy and Mass spectrometry analysis. (A) 1H-NMR; (B) 13C-NMR spectra; (C): Mass-Spectra. 
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Figure 4. Ursolic acid inhibited leukocyte 
migration in thioglycollate-induced mice. Mice 
were pretreated with HIF (400mg/kg BW), ursolic 
acid, solvent (DMSO–saline), or indomethacin 
(36mg/kg BW) 30min before the induction of 
leukocyte migration using thioglycollate (i.p.). The 
mice were sacrificed after 4 h and the peritoneum 
lavage was collected to calculate total leukocytes 
after staining with methylene blue. The data were 
means ± standard errors (*** p<0.01; ANOVA 
followed by Dunnett) and were relative to the 
solvent-treated group (n=5). 
 
 
 
Figure 5. Ursolic acid reduced the chemokine 
levels in thioglycollate-induced leukocyte migration 
in mice. Mice were pretreated with HIF (400mg/kg 
BW), ursolic acid, solvent (DMSO–saline) or 
indomethacin (36mg/kg BW) 30min before                 
the induction of leukocyte migration using 
thioglycollate (i.p.). The mice were sacrificed after 
4h, and the peritoneum lavage was collected to 
quantify the level of IL-8 and MCP-1 by ELISA. The 
data were presented as means ± standard errors 
(* p<0.05,  ** p<0.01; ANOVA  followed by Dunnett)  and 
were relative to the solvent-treated group (n=5). 
 
The in vivo anti-inflammatory activity of 
ursolic acid was evaluated in the mice leukocytes 
migration induced by thioglycollate. The ursolic 
acid inhibited leukocyte migration (Figure 4). The 
migration of leukocytes to inflammatory sites is 
directed by the chemokines, such as MCP-1 and IL-
8 (Gerszten et al., 1999; Shtein et al., 2012). To 
better understand the mechanism of action of 
ursolic acid in inhibiting leukocyte migration, we 
evaluated whether chemokines (IL-8 and MCP-1) 
expression was inhibited. Indeed, ursolic acid 
demonstrated a potent reduction in chemokine 
levels (Figure 5). Interestingly, ursolic acid 
reduced the MCP-1 level with a higher potency 
than IL-8. This result was in line with the previous 
study demonstrating that MCP-1 is the main 
chemokine responsible for leukocyte migration 
(Fakhrudin et al., 2017; Takahashi et al., 2009). 
This suggests that ursolic acid might be further 
examined for its efficacy against inflammatory-
related diseases in which MCP-1 plays crucial 
roles such as diabetic nephropathy (Tesch, 2008), 
cardiovascular diseases (Epstein et al., 2009), 
rheumatoid arthritis (Ellingsen et al., 2000), and 
angiogenesis (Chang et al., 2005).  This study 
calculated the total migration of leukocytes as a 
readout of inflammatory development. There              
are five different types of leukocytes (neutrophils, 
basophils, eosinophils, monocytes, and 
lymphocytes) with specific roles in inflammation. 
Among these cells, neutrophil plays a dominant 
role in the development of inflammatory related 
diseases (Wright et al., 2010). Interestingly, the 
dynamic expression of leukocyte innate immune 
genes influenced the pathogenesis of acute and 
chronic inflammation (Vinther et al., 2015). 
Further study might be required to reveal the 
dynamic changes of leukocytes composition upon 
ursolic acid treatment and its consequences for 
inflammatory development.  
Consistent with our findings, previous 
studies also showed the in vivo anti-inflammatory 
activities of ursolic acid in different models 
(Checker et al., 2012; Kashyap et al., 2016; 
Tapondjou et al., 2003). Nevertheless, our                 
study provides an update that ursolic acid 
inhibited leukocytes migration by reducing                
the level of chemokines (IL-8 and MCP-1).            
Since targeting leukocyte migration induced               
by chemokines is a promising approach to           
resolve inflammation (Hopkin et al., 2019),          
ursolic acid might represent a potential compound 
to  be   developed   as  an  anti-inflammatory agent. 
Although ursolic acid has been reported to exert 
anti-inflammatory activity by inhibition of pro-
inflammatory transcription factor such as NF-ĸB, 
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NF-AT, and AP-1, this result reveals an additional 
anti-inflammatory mechanism of action of ursolic 
acid (Checker et al., 2012). We also provides a 
scientific evidence for the traditional practice of 
utilizing the P. lanceolata leaf as an herbal remedy 
to treat inflammatory disorders (Dawid-Pać, 
2013). 
 
CONCLUSION 
In summary, we reported that ursolic acid 
from P. lanceolata leaves demonstrated an anti-
inflammatory activity by inhibiting leukocyte 
migration in mice. Additionally, the level of 
chemokines responsible for the leukocyte 
migration, IL-8 and MCP-1 were also reduced after 
ursolic acid treatment. Ursolic acid is an important 
pharmacological marker for P. lanceolata, which 
represents a promising plant for combating 
inflammatory-related disorders. 
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